Reproducibility of human cardiac phosphorus MRS (31P‐MRS) at 7 T

Purpose We test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a ‘rapid’ 6½ min 31P three‐dimensional chemical shift imaging (3D‐CSI) sequence, which if suff...

Full description

Saved in:
Bibliographic Details
Published inNMR in biomedicine Vol. 32; no. 6; pp. e4095 - n/a
Main Authors Ellis, Jane, Valkovič, Ladislav, Purvis, Lucian A.B., Clarke, William T., Rodgers, Christopher T.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.06.2019
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN0952-3480
1099-1492
1099-1492
DOI10.1002/nbm.4095

Cover

Abstract Purpose We test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a ‘rapid’ 6½ min 31P three‐dimensional chemical shift imaging (3D‐CSI) sequence, which if sufficiently reproducible would allow the study of stress‐response processes. We compare this with an established 28 min protocol, designed to record high‐quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per‐subject B0 shimming on data quality and reproducibility in the 6½ min protocol. Methods 10 healthy subjects were scanned on two occasions: one to test the 28 min 3D‐CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra‐ and intersubject variability. The impact of different strategies for voxel selection was assessed. Results There were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per‐subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66). Conclusions Both 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies. We test the reproducibility of two 3D 31P‐MRS CSI protocols at 7 T: one lasting 28 minutes and one lasting 6½ minutes. We observed improved reproducibility even in 6 ½ minutes at 7 T compared to previously reported results for a 31 minute scan at 3 T. Our findings can be used for power calculations when designing future clinical studies using 7 T 31P‐MRS as an endpoint.
AbstractList Purpose We test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a ‘rapid’ 6½ min 31P three‐dimensional chemical shift imaging (3D‐CSI) sequence, which if sufficiently reproducible would allow the study of stress‐response processes. We compare this with an established 28 min protocol, designed to record high‐quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per‐subject B0 shimming on data quality and reproducibility in the 6½ min protocol. Methods 10 healthy subjects were scanned on two occasions: one to test the 28 min 3D‐CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra‐ and intersubject variability. The impact of different strategies for voxel selection was assessed. Results There were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per‐subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66). Conclusions Both 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies. We test the reproducibility of two 3D 31P‐MRS CSI protocols at 7 T: one lasting 28 minutes and one lasting 6½ minutes. We observed improved reproducibility even in 6 ½ minutes at 7 T compared to previously reported results for a 31 minute scan at 3 T. Our findings can be used for power calculations when designing future clinical studies using 7 T 31P‐MRS as an endpoint.
We test the reproducibility of human cardiac phosphorus MRS ( P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a 'rapid' 6½ min P three-dimensional chemical shift imaging (3D-CSI) sequence, which if sufficiently reproducible would allow the study of stress-response processes. We compare this with an established 28 min protocol, designed to record high-quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per-subject B shimming on data quality and reproducibility in the 6½ min protocol. 10 healthy subjects were scanned on two occasions: one to test the 28 min 3D-CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra- and intersubject variability. The impact of different strategies for voxel selection was assessed. There were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per-subject B shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66). Both 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies.
We test the reproducibility of human cardiac phosphorus MRS (31 P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a 'rapid' 6½ min 31 P three-dimensional chemical shift imaging (3D-CSI) sequence, which if sufficiently reproducible would allow the study of stress-response processes. We compare this with an established 28 min protocol, designed to record high-quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per-subject B0 shimming on data quality and reproducibility in the 6½ min protocol.PURPOSEWe test the reproducibility of human cardiac phosphorus MRS (31 P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a 'rapid' 6½ min 31 P three-dimensional chemical shift imaging (3D-CSI) sequence, which if sufficiently reproducible would allow the study of stress-response processes. We compare this with an established 28 min protocol, designed to record high-quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per-subject B0 shimming on data quality and reproducibility in the 6½ min protocol.10 healthy subjects were scanned on two occasions: one to test the 28 min 3D-CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra- and intersubject variability. The impact of different strategies for voxel selection was assessed.METHODS10 healthy subjects were scanned on two occasions: one to test the 28 min 3D-CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra- and intersubject variability. The impact of different strategies for voxel selection was assessed.There were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per-subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66).RESULTSThere were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per-subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66).Both 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies.CONCLUSIONSBoth 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies.
PurposeWe test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a ‘rapid’ 6½ min 31P three‐dimensional chemical shift imaging (3D‐CSI) sequence, which if sufficiently reproducible would allow the study of stress‐response processes. We compare this with an established 28 min protocol, designed to record high‐quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per‐subject B0 shimming on data quality and reproducibility in the 6½ min protocol.Methods10 healthy subjects were scanned on two occasions: one to test the 28 min 3D‐CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra‐ and intersubject variability. The impact of different strategies for voxel selection was assessed.ResultsThere were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per‐subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66).ConclusionsBoth 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies.
Author Ellis, Jane
Rodgers, Christopher T.
Clarke, William T.
Purvis, Lucian A.B.
Valkovič, Ladislav
AuthorAffiliation 3 Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences University of Oxford UK
4 Wolfson Brain Imaging Centre, Department of Clinical Neurosciences University of Cambridge UK
2 Slovak Academy of Sciences Institute of Measurement Science Bratislava Slovakia
1 OCMR, RDM Cardiovascular Medicine University of Oxford UK
AuthorAffiliation_xml – name: 2 Slovak Academy of Sciences Institute of Measurement Science Bratislava Slovakia
– name: 3 Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences University of Oxford UK
– name: 4 Wolfson Brain Imaging Centre, Department of Clinical Neurosciences University of Cambridge UK
– name: 1 OCMR, RDM Cardiovascular Medicine University of Oxford UK
Author_xml – sequence: 1
  givenname: Jane
  orcidid: 0000-0002-2396-9741
  surname: Ellis
  fullname: Ellis, Jane
  email: jane.ellis@rdm.ox.ac.uk
  organization: University of Oxford
– sequence: 2
  givenname: Ladislav
  surname: Valkovič
  fullname: Valkovič, Ladislav
  organization: Institute of Measurement Science
– sequence: 3
  givenname: Lucian A.B.
  surname: Purvis
  fullname: Purvis, Lucian A.B.
  organization: University of Oxford
– sequence: 4
  givenname: William T.
  orcidid: 0000-0001-7159-7025
  surname: Clarke
  fullname: Clarke, William T.
  organization: University of Oxford
– sequence: 5
  givenname: Christopher T.
  surname: Rodgers
  fullname: Rodgers, Christopher T.
  organization: University of Cambridge
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30924566$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1uFDEQhS0URCYBiROgltiERQ9lt3_aGyQYQYiUAAphbbltN-Oouz2xu0Gz4wgcgbPkKJwknkwSfgQLq6yqz0-v_PbQzhAGh9BjDHMMQJ4PTT-nINk9NMMgZYmpJDtoljukrGgNu2gvpXMAqGlFHqDdCiShjPMZWpy6VQx2Mr7xnR_XRWiL5dTroTA6Wq9NsVqGlE-cUnFy-rE4qPCHn9--5-uzQo-FuPxx9hDdb3WX3KObuo8-vXl9tnhbHr8_PFq8PC4NrWpWtq1lBlvSCC0MZg3HnHAJxGjhiGjb3La2ZdhgwW3DJW8clrYBWdcZprLaRy-2uqup6Z01bhij7tQq-l7HtQraqz8ng1-qz-GL4oxyDiILHNwIxHAxuTSq3ifjuk4PLkxJEQIgRAWszujTv9DzMMUhr5cpwqlg-NrRk98d3Vm5_d8MzLeAiSGl6Fpl_KhHHzYGfacwqE2AKgeoNgH-snj34FbzH2i5Rb_6zq3_y6l3r06u-Su1zKkP
CitedBy_id crossref_primary_10_1007_s10334_023_01075_1
crossref_primary_10_1093_ehjci_jeac121
crossref_primary_10_1002_mrm_30492
crossref_primary_10_1007_s10741_022_10287_x
crossref_primary_10_3389_fphy_2020_00092
crossref_primary_10_2337_dc22_0083
crossref_primary_10_3390_diagnostics14030235
crossref_primary_10_1002_jmri_29445
crossref_primary_10_3389_fphys_2023_1325458
crossref_primary_10_1002_nbm_4950
crossref_primary_10_3389_fphys_2022_793987
crossref_primary_10_1002_mrm_28494
crossref_primary_10_1038_s41598_021_87063_8
crossref_primary_10_3389_fcvm_2023_1068390
crossref_primary_10_1002_mrm_28654
crossref_primary_10_1038_s41598_025_90630_y
crossref_primary_10_1002_nbm_4813
crossref_primary_10_3390_metabo12020189
crossref_primary_10_1371_journal_pone_0269957
Cites_doi 10.1002/nbm.701
10.1161/01.CIR.0000072789.89096.10
10.1259/bjr.71.847.9771379
10.1002/mrm.24922
10.1002/nbm.1192
10.1161/01.CIR.86.6.1810
10.1016/j.cardfail.2013.05.008
10.1007/s00330-006-0170-0
10.1081/JCMR-120016387
10.1148/radiol.2016152629
10.1136/hrt.2004.047985
10.1186/1532-429X-12-S1-P123
10.1002/mrm.1910250205
10.1161/CIRCULATIONAHA.109.934059
10.1056/NEJMra063052
10.1371/journal.pone.0187153
10.1371/journal.pone.0185356
10.1038/ncpcardio1158
10.1093/eurheartj/16.suppl_O.115
10.1002/mrm.1144
10.1006/jmre.1997.1244
10.1073/pnas.0408962102
10.1002/nbm.1350
10.3389/fphys.2017.00939
10.1161/01.CIR.92.1.15
10.1016/S0735-1097(02)02160-5
10.1002/mrm.22230
10.1002/(SICI)1099-1492(199608)9:5<217::AID-NBM419>3.0.CO;2-G
10.1080/01621459.1974.10482955
ContentType Journal Article
Copyright 2019 The Authors. published by John Wiley & Sons Ltd.
2019 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.
2019 John Wiley & Sons, Ltd.
Copyright_xml – notice: 2019 The Authors. published by John Wiley & Sons Ltd.
– notice: 2019 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.
– notice: 2019 John Wiley & Sons, Ltd.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
K9.
P64
7X8
5PM
DOI 10.1002/nbm.4095
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Physics
DocumentTitleAlternate Ellis et al
EISSN 1099-1492
EndPage n/a
ExternalDocumentID PMC6546607
30924566
10_1002_nbm_4095
NBM4095
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Medical Research Council
  funderid: HST00040/HS00.1
– fundername: Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
  funderid: #2/0001/17
– fundername: Agentúra na Podporu Výskumu a Vývoja
  funderid: #15‐0029
– fundername: Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society
  funderid: 098436/Z/12/B
– fundername: Agentúra na Podporu Výskumu a Vývoja
  grantid: #15-0029
– fundername: Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
  grantid: #2/0001/17
– fundername: Medical Research Council
  grantid: HST00040/HS00.1
– fundername: Wellcome Trust
  grantid: 098436
– fundername: Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society
  grantid: 098436/Z/12/B
– fundername: Agentúra na Podporu Výskumu a Vývoja
  grantid: #15‐0029
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
24P
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AIACR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P2Z
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAHHS
AAYXX
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
8FD
FR3
K9.
P64
7X8
5PM
ID FETCH-LOGICAL-c4385-ffd5c1d2b7a7c15b61626902ca7e27ff7a7ddf51c176db696be19db09885b6493
IEDL.DBID DR2
ISSN 0952-3480
1099-1492
IngestDate Thu Aug 21 18:27:31 EDT 2025
Fri Jul 11 03:12:13 EDT 2025
Fri Jul 25 09:58:20 EDT 2025
Mon Jul 21 06:02:39 EDT 2025
Thu Apr 24 23:08:58 EDT 2025
Tue Jul 01 02:45:42 EDT 2025
Thu Sep 25 07:34:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords 31P
7 T
human
reproducibility
MRS
cardiac
Language English
License Attribution
2019 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4385-ffd5c1d2b7a7c15b61626902ca7e27ff7a7ddf51c176db696be19db09885b6493
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2396-9741
0000-0001-7159-7025
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fnbm.4095
PMID 30924566
PQID 2226475149
PQPubID 2029982
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6546607
proquest_miscellaneous_2200773058
proquest_journals_2226475149
pubmed_primary_30924566
crossref_citationtrail_10_1002_nbm_4095
crossref_primary_10_1002_nbm_4095
wiley_primary_10_1002_nbm_4095_NBM4095
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2019
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: June 2019
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
– name: Hoboken
PublicationTitle NMR in biomedicine
PublicationTitleAlternate NMR Biomed
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
John Wiley and Sons Inc
Publisher_xml – name: Wiley Subscription Services, Inc
– name: John Wiley and Sons Inc
References 2010; 12
2009; 22
2017; 8
1995; 92
1995; 16
2006; 16
2010; 122
2002; 4
2008; 5
2016; 281
2004; 90
2001; 45
2010; 63
2007; 356
2013; 19
1974; 69
2003; 107
1997; 129
2005; 102
2002; 40
2017; 12
1992; 25
2014
1998; 71
1992; 86
2007; 20
2014; 72
2001; 14
1996; 9
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_12_1
Rodgers CT (e_1_2_8_13_1) 2014
e_1_2_8_30_1
References_xml – volume: 63
  start-page: 881
  issue: 4
  year: 2010
  end-page: 891
  article-title: Receive array magnetic resonance spectroscopy: whitened singular value decomposition (WSVD) gives optimal Bayesian solution
  publication-title: Magn Reson Med
– volume: 45
  start-page: 1095
  issue: 6
  year: 2001
  end-page: 1102
  article-title: BISTRO: an outer‐volume suppression method that tolerates RF field inhomogeneity
  publication-title: Magn Reson Med
– volume: 129
  start-page: 35
  issue: 1
  year: 1997
  end-page: 43
  article-title: Improved method for accurate and efficient quantification of MRS data with use of prior knowledge
  publication-title: J Magn Reson
– volume: 12
  issue: Suppl 1
  year: 2010
  article-title: Development and validation of a short 31P cardiac magnetic resonance spectroscopy protocol
  publication-title: J Cardiovasc Magn Reson
– volume: 12
  issue: 10
  year: 2017
  article-title: Using a whole‐body P birdcage transmit coil and 16‐element receive array for human cardiac metabolic imaging at 7T
  publication-title: PLoS ONE
– volume: 356
  start-page: 1140
  issue: 11
  year: 2007
  end-page: 1151
  article-title: The failing heart—an engine out of fuel
  publication-title: N Engl J Med
– year: 2014
  article-title: A 16‐element receive array for human cardiac 31P MR spectroscopy at 7T
  publication-title: Proc Int Soc Magn Reson Med
– volume: 281
  start-page: 409
  issue: 2
  year: 2016
  end-page: 417
  article-title: Dilated cardiomyopathy: phosphorus 31 MR spectroscopy at 7 T
  publication-title: Radiology
– volume: 69
  start-page: 364
  issue: 346
  year: 1974
  end-page: 367
  article-title: Robust tests for the equality of variances
  publication-title: J Am Stat Assoc
– volume: 122
  start-page: 1562
  issue: 16
  year: 2010
  end-page: 1569
  article-title: Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy
  publication-title: Circulation
– volume: 86
  start-page: 1810
  issue: 6
  year: 1992
  end-page: 1818
  article-title: 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high‐energy phosphate metabolism in heart failure
  publication-title: Circulation
– volume: 14
  start-page: 278
  issue: 4
  year: 2001
  end-page: 283
  article-title: Cramér‐Rao bounds: an evaluation tool for quantitation
  publication-title: NMR Biomed
– volume: 5
  start-page: S49
  year: 2008
  end-page: S56
  article-title: Detection of myocardial disorders by magnetic resonance spectroscopy
  publication-title: Nat Clin Pract Cardiovasc Med
– volume: 16
  start-page: 1796
  issue: 8
  year: 2006
  end-page: 1802
  article-title: P‐MR spectroscopic imaging in hypertensive heart disease
  publication-title: Eur Radiol
– volume: 8
  start-page: 939
  year: 2017
  article-title: Human cardiac P‐MR spectroscopy at 3 tesla cannot detect failing myocardial energy homeostasis during exercise
  publication-title: Front Physiol
– volume: 40
  start-page: 1267
  issue: 7
  year: 2002
  end-page: 1274
  article-title: Absolute concentrations of high‐energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with P‐SLOOP magnetic resonance spectroscopy
  publication-title: J Am Coll Cardiol
– volume: 16
  start-page: 115
  issue: Suppl O
  year: 1995
  end-page: 118
  article-title: Contributions of 31P‐magnetic resonance spectroscopy to the understanding of dilated heart muscle disease
  publication-title: Eur Heart J
– volume: 20
  start-page: 555
  issue: 6
  year: 2007
  end-page: 565
  article-title: Absolute quantification of phosphorus metabolite concentrations in human muscle by P MRS: a quantitative review
  publication-title: NMR Biomed
– volume: 72
  start-page: 304
  issue: 2
  year: 2014
  end-page: 315
  article-title: Human cardiac P magnetic resonance spectroscopy at 7 tesla
  publication-title: Magn Reson Med
– volume: 25
  start-page: 260
  issue: 2
  year: 1992
  end-page: 272
  article-title: Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus‐31 studies of normal and cardiomyopathic myocardium
  publication-title: Magn Reson Med
– volume: 9
  start-page: 217
  issue: 5
  year: 1996
  end-page: 227
  article-title: Reproducibility of human cardiac P‐NMR spectroscopy
  publication-title: NMR Biomed
– volume: 102
  start-page: 808
  issue: 3
  year: 2005
  end-page: 813
  article-title: ATP flux through creatine kinase in the normal, stressed, and failing human heart
  publication-title: Proc Natl Acad Sci
– volume: 12
  issue: 9
  year: 2017
  article-title: OXSA: an open‐source magnetic resonance spectroscopy analysis toolbox in MATLAB
  publication-title: PLoS ONE
– volume: 4
  start-page: 493
  issue: 4
  year: 2002
  end-page: 502
  article-title: Decreased high‐energy phosphate ratios in the myocardium of men with diabetes mellitus type I
  publication-title: J Cardiovasc Magn Reson
– volume: 90
  start-page: 23
  year: 2004
  end-page: 30
  article-title: BSE procedure guidelines for the clinical application of stress echocardiography, recommendations for performance and interpretation of stress echocardiography: a report of the British Society of Echocardiography Policy Committee
  publication-title: Heart
– volume: 19
  start-page: 454
  issue: 7
  year: 2013
  end-page: 460
  article-title: Exercise‐induced decrease in myocardial high‐energy phosphate metabolites in patients with Chagas heart disease
  publication-title: J Card Fail
– volume: 92
  start-page: 15
  issue: 1
  year: 1995
  end-page: 23
  article-title: Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by P magnetic resonance spectroscopy
  publication-title: Circulation
– volume: 107
  start-page: 3040
  issue: 24
  year: 2003
  end-page: 3046
  article-title: Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes
  publication-title: Circulation
– volume: 22
  start-page: 405
  issue: 4
  year: 2009
  end-page: 413
  article-title: Reproducibility of P cardiac magnetic resonance spectroscopy at 3 T
  publication-title: NMR Biomed
– volume: 71
  start-page: 704
  issue: 847
  year: 1998
  end-page: 707
  article-title: Signal‐to‐noise ratio in MRI
  publication-title: Br J Radiol
– ident: e_1_2_8_19_1
  doi: 10.1002/nbm.701
– ident: e_1_2_8_5_1
  doi: 10.1161/01.CIR.0000072789.89096.10
– ident: e_1_2_8_11_1
  doi: 10.1259/bjr.71.847.9771379
– ident: e_1_2_8_12_1
  doi: 10.1002/mrm.24922
– ident: e_1_2_8_22_1
  doi: 10.1002/nbm.1192
– ident: e_1_2_8_7_1
  doi: 10.1161/01.CIR.86.6.1810
– ident: e_1_2_8_28_1
  doi: 10.1016/j.cardfail.2013.05.008
– ident: e_1_2_8_6_1
  doi: 10.1007/s00330-006-0170-0
– ident: e_1_2_8_4_1
  doi: 10.1081/JCMR-120016387
– ident: e_1_2_8_21_1
  doi: 10.1148/radiol.2016152629
– ident: e_1_2_8_23_1
  doi: 10.1136/hrt.2004.047985
– ident: e_1_2_8_24_1
  doi: 10.1186/1532-429X-12-S1-P123
– ident: e_1_2_8_31_1
  doi: 10.1002/mrm.1910250205
– ident: e_1_2_8_30_1
  doi: 10.1161/CIRCULATIONAHA.109.934059
– year: 2014
  ident: e_1_2_8_13_1
  article-title: A 16‐element receive array for human cardiac 31P MR spectroscopy at 7T
  publication-title: Proc Int Soc Magn Reson Med
– ident: e_1_2_8_2_1
  doi: 10.1056/NEJMra063052
– ident: e_1_2_8_27_1
  doi: 10.1371/journal.pone.0187153
– ident: e_1_2_8_17_1
  doi: 10.1371/journal.pone.0185356
– ident: e_1_2_8_3_1
  doi: 10.1038/ncpcardio1158
– ident: e_1_2_8_10_1
  doi: 10.1093/eurheartj/16.suppl_O.115
– ident: e_1_2_8_14_1
  doi: 10.1002/mrm.1144
– ident: e_1_2_8_18_1
  doi: 10.1006/jmre.1997.1244
– ident: e_1_2_8_9_1
  doi: 10.1073/pnas.0408962102
– ident: e_1_2_8_16_1
  doi: 10.1002/nbm.1350
– ident: e_1_2_8_25_1
  doi: 10.3389/fphys.2017.00939
– ident: e_1_2_8_8_1
  doi: 10.1161/01.CIR.92.1.15
– ident: e_1_2_8_29_1
  doi: 10.1016/S0735-1097(02)02160-5
– ident: e_1_2_8_15_1
  doi: 10.1002/mrm.22230
– ident: e_1_2_8_26_1
  doi: 10.1002/(SICI)1099-1492(199608)9:5<217::AID-NBM419>3.0.CO;2-G
– ident: e_1_2_8_20_1
  doi: 10.1080/01621459.1974.10482955
SSID ssj0008432
Score 2.370349
Snippet Purpose We test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of...
We test the reproducibility of human cardiac phosphorus MRS ( P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this work...
PurposeWe test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of...
We test the reproducibility of human cardiac phosphorus MRS (31 P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e4095
SubjectTerms 31P
7 T
Adenosine triphosphate
Adenosine Triphosphate - metabolism
Adult
ATP
Biological products
cardiac
Chemical equilibrium
Female
Field strength
Heart
human
Humans
Magnetic Resonance Spectroscopy
Male
Motivation
MRS
Myocardium - metabolism
Organic chemistry
Phosphocreatine
Phosphocreatine - metabolism
Phosphorus
Phosphorus - metabolism
Reproducibility
Reproducibility of Results
Sample Size
Time Factors
Title Reproducibility of human cardiac phosphorus MRS (31P‐MRS) at 7 T
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fnbm.4095
https://www.ncbi.nlm.nih.gov/pubmed/30924566
https://www.proquest.com/docview/2226475149
https://www.proquest.com/docview/2200773058
https://pubmed.ncbi.nlm.nih.gov/PMC6546607
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0952-3480
  databaseCode: DR2
  dateStart: 19960101
  customDbUrl:
  isFulltext: true
  eissn: 1099-1492
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0008432
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2CSkA3PAYogVIZCfFYZBo7jh0vYURVIU1VlVaqxCLyU0UtmaqZWdBVP4FP4Fv4FL4E23nQoSAhFlGi-CZx7Gv72L73XIDnjmErrbWpLEqRUmNkKrgUKRfCA1inPagLC_rTHbZ9QN8fFoedVWXwhWn5IYYFt9AyYn8dGrhUzeYl0lD1eewnJ8G_HOdF3KHd-8UcVdIYm8ynkzSnZdbzzmZks39weSS6Ai-vWkleRq9x-Nm6Ax_7jLdWJ8fjxVyN9flvnI7_92d34XaHStGbVo3uwTVbj-DWpA8GN4Kb024PfgQ3otGobu7DxKP3SBjbWth-QTOHYsw_pKPeaXR6NGv8cbZo0HTvA3qV490fF1_95Wsk54h__7b_AA623u1PttMuKEOqaV4WqXOm0NgQxSXXuFAM-ymRyIiW3BLunL9tjCuwxpwZxQRTFgujMlGWXpiK_CGs1LPaPgJEnWGEulzkhtNCYGVFgJ9EOpUxoXECL_sKqnTHWB4CZ5xULdcyqXxJVaGkEng2SJ62LB1_kFnv67jq2mlTkeBHzD1oFP4VQ7Iv27BtIms7WwSZwHnk-8UygbVWJYaP5JkIO8csAb6kLINAYO9eTqk_HUUW7-BFxjKewIuoC3_Nd7XzdhrOj_9V8AmselQnWnu2dViZny3sU4-c5moDrhO6uxFbyk9iRBYq
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3LbtQwFL0qRVA2CIZXoICRENBFaOw4dixWMKIaoBlVMJW6i_xUkdpM1ZlZsOMT-AS-hU_hS7CdhzoqSCyiRPHNQ_f6cXx9fS7Ac8ewldbaVBalSKkxMhVcipQL4QGs0x7UBYd-NWWTQ_rxqDjagDf9XpiWH2JwuIWWEfvr0MCDQ3r3AmuoOn3tZyfFFbhKGclClSb0YOiGSxqzk3kBkua0zHrm2Yzs9k-uj0WXAOblOMmL-DUOQHu34GaHHNHb1tS3YcM2I9ga9wnbRnC96tbJR3AtBnbqxR0Ye4QdSV3bKNhvaO5QzMuHdKwbGp0dzxf-OF8tUPX5C3qV44Pf33_4yx0kl4j_-jm7C4d772fjSdolTkg1zcsidc4UGhuiuOQaF4phP20RGdGSW8Kd87eNcQXWmDOjmGDKYmFUJsrSC1OR34PNZt7YB4CoM4xQl4vccFoIrKwIEJFIpzImNE7gZa_CWnes4iG5xUnd8iGT2iu7DspO4NkgedYyafxFZru3Qt21pUVNwl5f7oGd8K8Yir1uw9KGbOx8FWQCL5Hvu8oE7rdGGz6SZyKs7rIE-Jo5B4HAsL1e0nw9jkzbYacXy3gCL6Lh__nf9fRdFc4P_1fwKWxNZtV-vf9h-ukR3PAoTLTxZ9uwuTxf2cce6SzVk1ij_wCfw_je
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2CItpueAwUUgoYCfFYZBonjh0vYWBUHjOqSitVYhH5qSIgM-rMLNoVn8An8C18Cl-C7TzoUJAQiyhRfJM49r32sX19LsBDS7ERxphY5AWPidYi5kzwmHHuAKxVDtT5Cf3RmO4ckNeH-WHjVen3wtT8EN2Em7eM0F57A59qu32GNFR-7rvBSX4RLhHqBlceEO39oo4qSAhO5gTSOCNF0hLPJul2--RyV3QOX553kzwLX0P_M7wK79uc124nH_uLueyr099IHf_v167BlQaWome1Hl2HC6bqwdqgjQbXg9VRswjfg8vBa1TNbsDAwffAGFu72J6giUUh6B9SQfEUmh5NZu44XszQaO8depLh3R9fvrrLp0jMEfv-bf8mHAxf7g924iYqQ6xIVuSxtTpXWKeSCaZwLil2YyKepEowkzJr3W2tbY4VZlRLyqk0mGuZ8KJwwoRnG7BSTSpzGxCxmqbEZjzTjOQcS8M9_kyFlQnlCkfwuK2gUjWU5T5yxqeyJltOS1dSpS-pCB50ktOapuMPMlttHZeNoc7K1G8kZg41cveKLtmVrV83EZWZLLyMJz1yDWMRwa1aJbqPZAn3S8c0ArakLJ2Ap-9eTqk-HAUab7-NjCYsgkdBF_6a73L8fOTPm_8qeB9Wd18My7evxm_uwLpDeLz2bduClfnxwtx1KGou7wVz-QnHHBge
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reproducibility+of+human+cardiac+phosphorus+MRS+%2831+P-MRS%29+at+7+T&rft.jtitle=NMR+in+biomedicine&rft.au=Ellis%2C+Jane&rft.au=Valkovi%C4%8D%2C+Ladislav&rft.au=Purvis%2C+Lucian+A+B&rft.au=Clarke%2C+William+T&rft.date=2019-06-01&rft.issn=1099-1492&rft.eissn=1099-1492&rft.volume=32&rft.issue=6&rft.spage=e4095&rft_id=info:doi/10.1002%2Fnbm.4095&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0952-3480&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0952-3480&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0952-3480&client=summon